« Back to Record
Citation APA

Desmedt, C., Sperinde, J., Piette, F., Huang, W., Jin, X., Tan, Y., Durbecq, V., Larsimont, D., Giuliani, R., Chappey, C., Buyse, M., Winslow, J., Piccart-Gebhart, M., Sotiriou, C., Petropoulos, C., & Bates, J. (2009). Quantitation of HER2 expression or HER2:HER2 dimers and differential survival in a cohort of metastatic breast cancer patients carefully selected for trastuzumab treatment primarily by FISH. Diagnostic molecular pathology, 18(1), 22-29. doi:10.1097/PDM.0b013e31818ebc69


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/54591

Desmedt, C., Sperinde, J., Piette, F., Huang, W., Jin, X., Tan, Y., Durbecq, V., Larsimont, D., Giuliani, R., Chappey, C., Buyse, M., Winslow, J., Piccart-Gebhart, M., Sotiriou, C., Petropoulos, C., & Bates, J. (2009). Quantitation of HER2 expression or HER2:HER2 dimers and differential survival in a cohort of metastatic breast cancer patients carefully selected for trastuzumab treatment primarily by FISH. Diagnostic molecular pathology, 18(1), 22-29. doi:10.1097/PDM.0b013e31818ebc69